Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018223922) USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/223922 International Application No.: PCT/CN2018/089762
Publication Date: 13.12.2018 International Filing Date: 04.06.2018
IPC:
A61K 36/756 (2006.01) ,A61K 36/718 (2006.01) ,A61K 36/66 (2006.01) ,A61K 36/539 (2006.01) ,A61K 35/644 (2015.01) ,A61K 31/575 (2006.01) ,A61P 31/04 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
185
Magnoliopsida (dicotyledons)
75
Rutaceae (Rue family)
756
Phellodendron, e.g. corktree
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
185
Magnoliopsida (dicotyledons)
71
Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
718
Coptis (goldthread)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
185
Magnoliopsida (dicotyledons)
66
Papaveraceae (Poppy family), e.g. bloodroot
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
185
Magnoliopsida (dicotyledons)
53
Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
539
Scutellaria (skullcap)
[IPC code unknown for A61K 35/644]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
575
substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04
Antibacterial agents
Applicants:
李俐 LI, Li [US/US]; US
北京荣祥再生医学研究所有限公司 BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE CO., LTD. [CN/CN]; 中国北京市 北京经济技术开发区西环南路26号院9号楼 Building 9, Yard No. 26, West Ring Southern Road, Beijing Economic and Technological Development Zone Beijing 100176, CN
Inventors:
李俐 LI, Li; US
Agent:
北京戈程知识产权代理有限公司 GE CHENG & CO., LTD.; 中国北京市 东城区东长安街1号东方广场东三办公楼19层 Level 19 Tower E3, The Towers, Oriental Plaza, No.1, East Chang An Avenue, Dongcheng District Beijing 100738, CN
Priority Data:
201710417831.206.06.2017CN
Title (EN) USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI
(FR) UTILISATION D'UNE COMPOSITION PHARMACEUTIQUE DANS LA PRÉPARATION D'UN MÉDICAMENT CONTRE HELICOBACTER PYLORI
(ZH) 药物组合物在制备用于抗幽门螺杆菌的药物中的用途
Abstract:
(EN) A use of a pharmaceutical composition in preparing a drug against Helicobacter pylori. The pharmaceutical composition is suitable for oral administration and comprises a homogeneous mixture of edible oil, beeswax, and β-sitosterol. The beeswax in the composition forms microcrystals. Based on the total weight of the composition, the content of the beeswax is 0.5-50%, and the content of the β-sitosterol is 0.1-20%. The pharmaceutical composition can be used in inhibiting or killing Helicobacter pylori and in treating or preventing a disease caused by Helicobacter pylori.
(FR) L'invention concerne l'utilisation d'une composition pharmaceutique dans la préparation d'un médicament contre Helicobacter pylori. La composition pharmaceutique se prête à une administration par voie orale et comprend un mélange homogène d'huile comestible, de cire d'abeille et de β-sitostérol. La cire d'abeille dans la composition forme des microcristaux. Sur la base du poids total de la composition, la teneur en cire d'abeille est de 0,5 à 50 %, et la teneur en β-sitostérol est de 0,1 à 20 %. La composition pharmaceutique selon l'invention peut être utilisée pour inhiber ou tuer Helicobacter pylori et pour traiter ou prévenir une maladie provoquée par Helicobacter pylori.
(ZH) 一种药物组合物在制备用于抗幽门螺杆菌的药物中的用途,其中所述的药物组合物是一种适用于口服的药物组合物,包括食用油与蜂蜡、β-谷甾醇的均质混合物,其中,该组合物中蜂蜡形成微晶体,按该组合物总重量计算,蜂蜡的含量为0.5-50%,β-谷甾醇为0.1-20%。该药物组合物可用于抑制或杀灭幽门螺杆菌,以及用于治疗或预防由幽门螺杆菌引起的疾病。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)